Skip to main content
Log in

Screening and functional analysis of differentially expressed lncRNAs in rapid atrial pacing dog atrial tissue

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Purpose

Atrial fibrillation (AF) is one of the most commonly sustained arrhythmias in clinical practice. Long non-coding RNAs (lncRNAs) are gene regulatory elements involved in the development of several diseases. We aimed to explore the expression characteristics of lncRNAs associated with AF.

Methods

We randomly assigned 12 adult healthy mongrel dogs into a control group and an atrial pacing group. Atrial pacing stimulation was performed at a high frequency of 500 beats per min for 14 consecutive days in the atrial pacing group. HE and Masson staining were used to detect rapid atrial pacing induced atrial fibrosis. Total RNA extraction was performed on dog atrial tissues and was used for high-throughput sequencing of lncRNAs.

Results

A total of 10,310 lncRNAs were detected, and 33 differentially expressed lncRNAs were screened. Among them, 19 lncRNAs were upregulated in the atrial pacing group, and 14 lncRNAs were downregulated. Gene Ontology (GO) classification, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, and interaction networks showed that AF-related lncRNAs participate in the regulation of AF in diverse biological processes, cellular components, molecular functions, signaling pathways, and complex interactions with miRNAs and mRNAs. Five differentially expressed lncRNAs were selected for RT-PCR validation, and the verification results were consistent with the results of lncRNA sequencing.

Conclusions

In summary, our study enhances our understanding of the biological functions of AF-related lncRNAs by screening and analyzing differentially expressed lncRNAs, and the results help to enrich the theoretical basis for the treatment of atrial fibrillation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006;8:651–745.

    Article  PubMed  Google Scholar 

  2. Munger TM, Wu LQ, Shen WK. Atrial fibrillation. J Biomed Res. 2014;28:1–17.

    PubMed  Google Scholar 

  3. Caplan LR. Atrial fibrillation, past and future: from a stroke non-entity to an over-targeted cause. Cerebrovasc Dis. 2018;45:149–53.

    Article  PubMed  Google Scholar 

  4. Lindberg T, Wimo A, Elmstahl S, Qiu C, Bohman DM, Sanmartin Berglund J. Prevalence and incidence of atrial fibrillation and other arrhythmias in the general older population: findings from the Swedish National Study on Aging and Care. Gerontol Geriatr Med. 2019;5:2333721419859687.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012;9:632–696.e621.

    Article  PubMed  Google Scholar 

  6. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82:2N–9N.

    Article  CAS  PubMed  Google Scholar 

  7. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129:837–47.

    Article  Google Scholar 

  8. Ko D, Rahman F, Schnabel RB, Yin X, Benjamin EJ, Christophersen IE. Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol. 2016;13:321–32.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Liu X, Li Y, Zhang H, Ji Y, Zhao Z, Wang C. The research of ion channel-related gene polymorphisms with atrial fibrillation in the Chinese Han population. Mol Genet Genomic Med. 2019;7:e835.

    PubMed  PubMed Central  Google Scholar 

  10. Corden B, Jarman J, Whiffin N, Tayal U, Buchan R, Sehmi J, et al. Association of titin-truncating genetic variants with life-threatening cardiac arrhythmias in patients with dilated cardiomyopathy and implanted defibrillators. JAMA Netw Open. 2019;2:e196520.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Alsina KM, Hulsurkar M, Brandenburg S, Kownatzki-Danger D, Lenz C, Urlaub H, et al. Loss of protein phosphatase 1 regulatory subunit PPP1R3A promotes atrial fibrillation. Circulation. 2019;140:681–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Jiang T, Wang YN, Qu Q, Qi TT, Chen YD, Qu J. Association between gene variants and the recurrence of atrial fibrillation: an updated meta-analysis. Medicine. 2019;98:e15953.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Santulli G, Iaccarino G, De Luca N, Trimarco B, Condorelli G. Atrial fibrillation and microRNAs. Front Physiol. 2014;5:15.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lee C, Kikyo N. Strategies to identify long noncoding RNAs involved in gene regulation. Cell Biosci. 2012;2:37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Bolha L, Ravnik-Glavac M. Long noncoding RNAs as biomarkers in cancer. Dis Markers. 2017;2017:7243968.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Fernandes JCR, Acuna SM, Aoki JI, Floeter-Winter LM, Muxel SM. Long non-coding RNAs in the regulation of gene expression: physiology and disease. Noncod RNA. 2019;5:17.

    CAS  Google Scholar 

  17. Li H, Ma SQ, Huang J, Chen XP, Zhou HH. Roles of long noncoding RNAs in colorectal cancer metastasis. Oncotarget. 2017;8:39859–76.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Zhang Y, Du W, Yang B. Long non-coding RNAs as new regulators of cardiac electrophysiology and arrhythmias: molecular mechanisms, therapeutic implications and challenges. Pharmacol Ther. 2019;107389.

  19. Charles Richard JL, Eichhorn PJA. Platforms for investigating LncRNA functions. SLAS Technol. 2018;23:493–506.

    PubMed  PubMed Central  Google Scholar 

  20. Liu E, Yang S, Xu Z, Li J, Yang W, Li G. Angiotensin-(1-7) prevents atrial fibrosis and atrial fibrillation in long-term atrial tachycardia dogs. Regul Pept. 2010;162:73–8.

    Article  CAS  PubMed  Google Scholar 

  21. Li X, Luo S, Zhang J, Yuan Y, Jiang W, Zhu H, et al. lncRNA H19 alleviated myocardial I/RI via suppressing miR-877-3p/Bcl-2-mediated mitochondrial apoptosis. Mol Ther Nucleic Acids. 2019;17:297–309.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Greco S, Gaetano C, Martelli F. Long noncoding competing endogenous RNA networks in age-associated cardiovascular diseases. Int J Mol Sci. 2019;20:3079.

    Article  CAS  PubMed Central  Google Scholar 

  23. Monteiro JP, Bennett M, Rodor J, Caudrillier A, Ulitsky I, Baker AH. Endothelial function and dysfunction in the cardiovascular system: the long non-coding road. Cardiovasc Res. 2019;115:1692–704.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kowatsch C, Woolley RE, Kinnebrew M, Rohatgi R, Siebold C. Structures of vertebrate patched and smoothened reveal intimate links between cholesterol and hedgehog signalling. Curr Opin Struct Biol. 2019;57:204–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Santulli G, D'Ascia SL, D'Ascia C. Development of atrial fibrillation in recipients of cardiac resynchronization therapy: the role of atrial reverse remodelling. Can J Cardiol. 2012;28:245.e17.

    Article  Google Scholar 

  26. Brundel BJ, Van Gelder IC, Henning RH, Tuinenburg AE, Wietses M, Grandjean JG, et al. Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels. J Am Coll Cardiol. 2001;37:926–32.

    Article  CAS  PubMed  Google Scholar 

  27. Tajiri K, Guichard JB, Qi X, Xiong F, Naud P, Tardif JC, et al. An N−/L-type calcium channel blocker, cilnidipine, auppresses autonomic, electrical and structural remodeling associated with atrial fibrillation. Cardiovasc Res. 2019;115:1975–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Hu HJ, Zhang C, Tang ZH, Qu SL, Jiang ZS. Regulating the Warburg effect on metabolic stress and myocardial fibrosis remodeling and atrial intracardiac waveform activity induced by atrial fibrillation. Biochem Biophys Res Commun. 2019;516:653–60.

    Article  CAS  PubMed  Google Scholar 

  29. Maille B, Das M, Hussein A, Shaw M, Chaturvedi V, Williams E, et al. Reverse electrical and structural remodeling of the left atrium occurs early after pulmonary vein isolation for persistent atrial fibrillation. J Interv Card Electrophysiol. 2020;58:9–19.

    Article  PubMed  Google Scholar 

  30. Paulis L, Fauconnier J, Cazorla O, Thireau J, Soleti R, Vidal B, et al. Activation of sonic hedgehog signaling in ventricular cardiomyocytes exerts cardioprotection against ischemia reperfusion injuries. Sci Rep. 2015;5:7983.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008;51:802–9.

    Article  CAS  PubMed  Google Scholar 

  32. Jalife J, Kaur K. Atrial remodeling, fibrosis, and atrial fibrillation. Trends Cardiovasc Med. 2015;25:475–84.

    Article  CAS  PubMed  Google Scholar 

  33. Pellman J, Sheikh F. Atrial fibrillation: mechanisms, therapeutics, and future directions. Compr Physiol. 2015;5:649–65.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Gao Y, Gong Y. Simulation of atrial fibrosis using coupled myocyte-fibroblast cellular and human atrial models. Comput Math Methods Med. 2017;2017:9463010.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Menon A, Hong L, Savio-Galimberti E, Sridhar A, Youn SW, Zhang M, et al. Electrophysiologic and molecular mechanisms of a frameshift NPPA mutation linked with familial atrial fibrillation. J Mol Cell Cardiol. 2019;132:24–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Willoughby SR, Roberts-Thomson RL, Lim HS, Schultz C, Prabhu A, de Sciscio P, et al. Atrial platelet reactivity in patients with atrial fibrillation. Heart Rhythm. 2010;7:1178–83.

    Article  PubMed  Google Scholar 

  37. Lenski M, Schleider G, Kohlhaas M, Adrian L, Adam O, Tian Q, et al. Arrhythmia causes lipid accumulation and reduced glucose uptake. Basic Res Cardiol. 2015;110:40.

    Article  PubMed  Google Scholar 

  38. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, van Wagoner DR, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 2001;104:174–80.

    Article  CAS  PubMed  Google Scholar 

  39. Watschinger K, Werner ER. Orphan enzymes in ether lipid metabolism. Biochimie. 2013;95:59–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Daniel H, Levenes C, Crépel F. Cellular mechanisms of cerebellar LTD. Trends Neurosci. 1998;21:401–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Availability of data and material

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Code availability

Not applicable.

Funding

The present study was approved by the Science & Technology Development Fund of Tianjin Education Commission for Higher Education(No. 2018KJ058).

Author information

Authors and Affiliations

Authors

Contributions

Xue Liang and Enzhao Liu made substantial contributions to the conception and design of the present study; Lijun Wang and Jiageng Cai acquired the data; Wenfeng Shangguan and Rukun Cheng performed the experiments; Baoshuai Zhang and Tong Liu analyzed and interpreted the data; Xue Liang and Enzhao Liu were involved in drafting the manuscript and revising it critically for important intellectual content. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Enzhao Liu or Xue Liang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval and consent to participate

The present study was approved by the Experimental Animal Administration Committee of Tianjin Medical University and Tianjin Municipal Commission for Experimental Animal Control (IRM-DWLL-2019018).

Consent for publication

Written informed consent for publication was obtained from all participants.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shangguan, W., Wang, L., Cheng, R. et al. Screening and functional analysis of differentially expressed lncRNAs in rapid atrial pacing dog atrial tissue. J Interv Card Electrophysiol 61, 375–384 (2021). https://doi.org/10.1007/s10840-020-00824-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-020-00824-9

Keywords

Navigation